Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS).
about
Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases.Acute myeloid leukemia in older adults.To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century.Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients.How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML.
P2860
Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Intensive chemotherapy for eld ...... Clinical Study Group (J-HOCS).
@en
Intensive chemotherapy for eld ...... Oncology Clinical Study Group
@nl
type
label
Intensive chemotherapy for eld ...... Clinical Study Group (J-HOCS).
@en
Intensive chemotherapy for eld ...... Oncology Clinical Study Group
@nl
prefLabel
Intensive chemotherapy for eld ...... Clinical Study Group (J-HOCS).
@en
Intensive chemotherapy for eld ...... Oncology Clinical Study Group
@nl
P2093
P2860
P1433
P1476
Intensive chemotherapy for eld ...... Clinical Study Group (J-HOCS)
@en
P2093
Kenshi Suzuki
Kensuke Usuki
Kinuko Mitani
Kumi Oshima
Mineo Kurokawa
Tsuyoshi Takahashi
Wataru Takahashi
Yasunori Nakagawa
Yoshinobu Kanda
Yuki Asano-Mori
P2860
P304
P356
10.1007/S00277-012-1487-1
P50
P577
2012-05-11T00:00:00Z